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were given for the following events: Initial contact, peak knee ﬂexion
and toe-off. In addition knee and hip excursion (ROM) were calculated.
Moments were given as internal moments.
Results: Fifty-two patients, 33 women and 20 men, with a mean
age of 60.3 (range 39.9–80.6) years were included. Of these, 12 had
bilateral hip OA. Mean MJS in the affected hip joints was 2.01 (SD 1.14)
mm, and mean HHS score 78.3 (SD 8.0). There were no signiﬁcant
differences between the PE and the PE+ET group at baseline. Signiﬁcant
differences were established in gait characteristics between the affected
and unaffected hip joints at baseline, in that knee and hip excursion
(ROM) were decreased, and hip and knee extension moments at peak
knee ﬂexion were reduced in the affected joints (p < 0.05). There were no
signiﬁcant differences between the two intervention groups at follow-
up. However, a signiﬁcant improvement was found in knee extension
moment (p = 0.046) on the affected side, but not the unaffected, in both
groups.
Conclusions: Gait characteristics during the stance phase of gait were
signiﬁcantly altered in the affected joints already at the stage of hip OA
when patients have mild to moderate pain. There were no signiﬁcant
differences between the two intervention groups at follow-up.
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Purpose: There has been a huge interest in the involvement of Toll-
Like Receptors (TLR) in human and experimental arthritis. Several
endogenous ligands for TLR-2, like biglycan, hyaluronan or HMGB-1, are
present in osteoarthritic joints. However, the involvement of this receptor
in osteoarthritis (OA) has not been studied extensively. The present
study was performed to evaluate the role of TLR-2 in experimental OA
pathology.
Methods: Three different models for OA were used, collagenase
induced OA (CIOA), destabilization of the medial meniscus (DMM) and
spontaneous OA in IL-1ra−/− murine knee joints. CIOA was induced by 2
intra-articular injections of 1 Unit collagenase into murine knee joints.
Due to the instability that results from these injections, OA-like pathology
develops within 42 days. At day 42, knee joints are dissected and
processed for histological examination. DMM was induced by surgical
transsection of the ligament that stabilizes the medial meniscus, which
results in an OA-like phenotype within 56 days. OA-like changes in
the cartilage of 4 joint surfaces were scored using a modiﬁed Pritzker
score. Five sections of each joint were scored. The role of TLR2 was
studied by induction of CIOA and DMM OA in TLR2−/− mice (n =16) and
C57BL/6 controls (n = 15), and by backcrossing of TLR-2−/− mice to IL-1-
ra−/− mice. At different time points during OA development, synovial
tissue was isolated to study TLR-2 expression in the wild type (WT)
mice by Q-PCR.
Results: Synovial activation, indicated by thickening of the synovial lining
layer, was studied in the three OA models. During CIOA and to a lesser
extend in the IL-1ra−/− mice, synovial activation was clearly present
during the whole course of the disease. However, no synovial activation
was observed in the DMM model. At day 7 after induction of CIOA in
WT mice, synovial TLR-2 levels were upregulated up to 56 fold, probably
a reﬂection of cellular inﬂux at this time point. At day 21 TLR2 levels
were up 2-fold and 42 after induction, TLR-2 levels in the synovium
were down to levels found in naïve mice. In the DMM model, TLR-2 was
not regulated at any of these time points.During CIOA in TLR2−/− mice,
OA cartilage pathology increased from 10.0 in the wildtype controls to
15.5 (p < 0.02). Changes were observed in all surfaces, but were strongest
in the lateral compartment of the joint, both in the femur and tibia.
Incidence of severe cartilage damage was increased in the medial femur,
medial tibia, lateral femur and lateral tibia respectively from 13% to 44%,
from 27% to 69%, from 60% to 81% and from 53% to 81%. In knee joints of
IL-1ra−/− mice, damage was less severe compared to CIOA WT mice with
a mean score of 2.2 and showed an increase in the IL-1ra−/−/TLR2−/− up to
a score of 4.1. In contrast, cartilage pathology during DMM OA in TLR2−/−
was not changed in the medial compartment of the joints, compared
to WT mice, respectively 13.7 and 14.7. Severe cartilage damage did not
differ between WT and TLR2−/−, 30% and 40% respectively. In all models,
synovial activation in TLR-2−/− mice was comparable to the WT, indicating
no direct role for TLR-2 in synovial activation.
Conclusions: In contrast to our expectations, these studies indicate that
in TLR2 deﬁcient mice OA pathology is more severe in experimental OA
that involves synovial activation. This suggests a protective role for this
receptor in OA, in stead of the inducing roles that were anticipated. This
protective role was abolished in the absence of synovial activation, as
was found in the DMM model. The mechanisms via which TLR2 exerts
this effect remain unclear, although stimulation of TLR2 by endogenous
ligands such as biglycan, hyaluronan or HMGB-1 has been shown to
induce IL-10, TGFb and HGF, which are protective mediators for OA.
Although further research is needed, these results indicate that during
OA the TLR-2 pathway protects cartilage from developing OA and that this
effect is mediated by the synovium. These ﬁndings may have important
implications for future therapies.
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Purpose: Synovial inﬂammation is detectable in osteoarthritis (OA)
patients as well as patients with meniscal injuries, and this synovitis is
associated with symptoms. Inﬂammation in OA is thought to be triggered
in part by products of tissue degradation via stimulation of innate
pattern-recognition receptors such as the Toll-like Receptors (TLRs).
Many endogenous ligands of Toll-like receptors have been described,
some of which are present in the OA and injured joint. We tested whether
a TLR-2 or TLR-4 stimulating factor could be detected in synovial ﬂuid
(SF) from early knee OA patients, and lead to inﬂammatory activation of
synoviocytes.
Methods: SF was obtained from patients with early OA undergoing
arthroscopic meniscal procedures. HEK293 cells transfected with either
TLR-4, or TLR-4 + MD2, or transfected with CD14 or TLR-2 + CD14
were used to screen SF for the ability to induce IL-8 production. Primary
cultures of ﬁbroblast-like synoviocytes (FLS) were established from post-
mortem tissue donors, and also stimulated with a TLR-4 stimulus (LPS),
a TLR-2 stimulus (Pam3Cysk4) SF alone, or SF in combination with LPS or
Pam3CysK4. Interleukin-8 (IL-8) in culture supernatants was measured
by ELISA. In blocking experiments, SF was pre-incubated with anti-CD14
(clone MEM-18) prior to using as stimuli for FLS cultures.
Results: SF from these patients did not generally stimulate HEK
transfectants. However, the addition of SF (0.09–25%) in combination
with TLR-2 or TLR-4 ligands resulted in signiﬁcant augmentation (up to
100-fold) of cytokine production from both the HEK transfectants and
from primary FLS. Levels of sCD14, a co-receptor for both TLR-2 and
TLR-4, were measured in SFs from early OA patients and found at levels
comparable to advanced OA and Rheumatoid Arthritis. Treatment with
anti-CD14 abolished the ability of SF to augment IL-8 production by FLS
in response to LPS, and diminished Pam3CysK4 responses.
Conclusions: In vitro, SF augments the response of FLS to both TLR-2 and
-4 ligands. This effect appeared to be largely due to sCD14, particularly in
response to the TLR-4 ligand LPS. As synoviocytes are expected to be in
contact with SF in vivo, these results suggest that SF sCD14 in the setting
of OA and meniscal injury can sensitize FLS to respond to inﬂammatory
stimuli such as TLR ligands. We speculate that this priming of FLS
inﬂammatory responses may have relevance to symptomatic “ﬂares”
seen clinically in OA patients.
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Purpose: As shown in previous studies, the infrapatellar fat pad (IFP)
of OA patients has an inﬂammatory phenotype and could contribute
to the biological processes in the OA knee joint. We have previously
characterized the immune cell inﬁltrate in the IFP and have shown
the presence of CD4+ T cells. Because several studies have shown that
the phenotype of CD4+ T cells in adipose tissue is changing with the
